Investor Presentaiton
RMS Segment
Foundational tools for the discovery of new molecules
#1
Global RMS position
Research Products
Production and distribution of
the most widely used
small research models, as
well as cellular products
Services
Flexible solutions that
support our clients' use of
models and the screening of
drug candidates
~40%
Global RMS share
-1 of 2
Small research models sold in
North America and Europe
from CRL
- Global footprint ensures proximity to
major biohubs
- Consistent, high-quality source of small
research models provides critical link
to DSA business
- Creative strategies, including CRADL™,
to attract emerging biopharma clients at
earlier stages
- Enhanced digital enterprise improves
efficiency and client experience
~150
of the most widely used
research model strains
Charles River Laboratories (CRL)
Note: CRL market share data based on management estimates and publicly available information.
8View entire presentation